157 related articles for article (PubMed ID: 18157525)
21. Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism.
Djordjevic N; Radmanovic B; Cukic J; Baskic D; Djukic-Dejanovic S; Milovanovic D; Aklillu E
World J Biol Psychiatry; 2020 Jan; 21(1):29-52. PubMed ID: 30513034
[No Abstract] [Full Text] [Related]
22. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
[TBL] [Abstract][Full Text] [Related]
23. CYP1A2 in a smoking and a non-smoking population; correlation of urinary and salivary phenotypic ratios.
Woolridge H; Williams J; Cronin A; Evans N; Steventon GB
Drug Metabol Drug Interact; 2004; 20(4):247-61. PubMed ID: 15663294
[TBL] [Abstract][Full Text] [Related]
24. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism.
Chung WG; Kang JH; Park CS; Cho MH; Cha YN
Clin Pharmacol Ther; 2000 Mar; 67(3):258-66. PubMed ID: 10741629
[TBL] [Abstract][Full Text] [Related]
25. CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study.
Gkouskou KG; Georgiopoulos G; Vlastos I; Lazou E; Chaniotis D; Papaioannou TG; Mantzoros CS; Sanoudou D; Eliopoulos AG
Int J Obes (Lond); 2022 Jan; 46(1):162-168. PubMed ID: 34564706
[TBL] [Abstract][Full Text] [Related]
26. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol.
Le Marchand L; Franke AA; Custer L; Wilkens LR; Cooney RV
Pharmacogenetics; 1997 Feb; 7(1):11-9. PubMed ID: 9110357
[TBL] [Abstract][Full Text] [Related]
27. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
[TBL] [Abstract][Full Text] [Related]
28. Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.
Wittayalertpanya S; Hinsui Y; Lawanprasert S
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S310-7. PubMed ID: 12930004
[TBL] [Abstract][Full Text] [Related]
29. Caffeine induces CYP1A2 expression in rat hepatocytes but not in human hepatocytes.
Vaynshteyn D; Jeong H
Drug Metab Lett; 2012 Jun; 6(2):116-9. PubMed ID: 23167901
[TBL] [Abstract][Full Text] [Related]
30. Use of caffeine as a probe for rapid determination of cytochrome P-450 CYP1A2 activity in humans.
Ou-Yang DS; Huang SL; Xie HG; Wang CY; Zhou HH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):44-6. PubMed ID: 10375757
[TBL] [Abstract][Full Text] [Related]
31. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.
Chuang YH; Lill CM; Lee PC; Hansen J; Lassen CF; Bertram L; Greene N; Sinsheimer JS; Ritz B
Neuroepidemiology; 2016; 47(3-4):192-200. PubMed ID: 28135712
[TBL] [Abstract][Full Text] [Related]
32. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
[TBL] [Abstract][Full Text] [Related]
33. Coffee, CYP1A2 genotype, and risk of myocardial infarction.
Cornelis MC; El-Sohemy A; Kabagambe EK; Campos H
JAMA; 2006 Mar; 295(10):1135-41. PubMed ID: 16522833
[TBL] [Abstract][Full Text] [Related]
34. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
Palatini P; Ceolotto G; Ragazzo F; Dorigatti F; Saladini F; Papparella I; Mos L; Zanata G; Santonastaso M
J Hypertens; 2009 Aug; 27(8):1594-601. PubMed ID: 19451835
[TBL] [Abstract][Full Text] [Related]
35. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases.
Zhou A; Hyppönen E
Am J Clin Nutr; 2019 Mar; 109(3):509-516. PubMed ID: 30838377
[TBL] [Abstract][Full Text] [Related]
36. A population and family study of CYP1A2 using caffeine urinary metabolites.
Catteau A; Bechtel YC; Poisson N; Bechtel PR; Bonaïti-Pellie C
Eur J Clin Pharmacol; 1995; 47(5):423-30. PubMed ID: 7720764
[TBL] [Abstract][Full Text] [Related]
37. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.
Bågeman E; Ingvar C; Rose C; Jernström H
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):895-901. PubMed ID: 18398030
[TBL] [Abstract][Full Text] [Related]
38. Habitual coffee consumption and risk of dementia in older persons: modulation by CYP1A2 polymorphism.
Lefèvre-Arbogast S; Helmer C; Berr C; Debette S; Samieri C
Eur J Epidemiol; 2024 Jan; 39(1):81-86. PubMed ID: 37906419
[TBL] [Abstract][Full Text] [Related]
39. Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking.
Dobrinas M; Cornuz J; Pedrido L; Eap CB
Pharmacogenet Genomics; 2012 Feb; 22(2):143-51. PubMed ID: 22246422
[TBL] [Abstract][Full Text] [Related]
40. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
Simonsson M; Söderlind V; Henningson M; Hjertberg M; Rose C; Ingvar C; Jernström H
Cancer Causes Control; 2013 May; 24(5):929-40. PubMed ID: 23412805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
